The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.

Christopher Paul MillwardSumirat M KeshwaraTerri S ArmstrongHeather BarringtonSabrina BellAndrew R BrodbeltHelen BulbeckLinda DirvenPaul L GrundyAbdurrahman I IslimMohsen JavadpourShelli D KoszdinAnthony G MarsonMichael W McDermottTorstein R MelingKathy OliverPuneet PlahaMatthias PreusserThomas SantariusNisaharan SrikandarajahMartin J B TaphoornCarole TurnerColin WattsMichael WellerPaula R WilliamsonGelareh ZadehAmir H Zamanipoor NajafabadiMichael D Jenkinsonnull null

Published in: Neuro-oncology advances (2024)

Outcome measurement across meningioma clinical trials is heterogeneous. The standardized outcome terms identified will be prioritized through an eDelphi survey and consensus meeting of key stakeholders (including patients), in order to develop a core outcome set for use in future meningioma clinical trials.

Keyphrases

clinical trial
optic nerve
end stage renal disease
phase ii
newly diagnosed
chronic kidney disease
peritoneal dialysis
open label
prognostic factors
study protocol
skeletal muscle
optical coherence tomography
placebo controlled